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Abstract
Background:  Flaps are currently the predominant method of reconstruction for irradiated
wounds. The usefulness of split-thickness skin grafts (STSG) in this setting remains controversial.
The purpose of this study is to examine the outcomes of STSGs in conjunction with VAC therapy
used in the treatment of irradiated extremity wounds.
Methods:  The records of 17 preoperatively radiated patients with extremity sarcomas
reconstructed with STSGs in conjunction with VAC® therapy were reviewed regarding details of
radiation treatment, wound closure, and outcomes.
Results: STSGs healed without complications (>95% of the graft take) in 12 (71%). Minor loss (6%
– 20% surface) was noted in 3 patients (17.6%) and complete loss in 2 (11.7%). Two patients (11.7%)
required flap reconstructions and 12 (88%) healed without further operative procedures.
Conclusion: Although flap coverage is an established treatment for radiated wounds, STSG in
conjunction with liberal utilization of VAC therapy is an alternative for selected patients where
acceptable soft tissue bed is preserved. Healing of the preoperatively radiated wounds can be
achieved in the vast majority of such patients with minimal need for additional reconstructive
operations.
Background
Reconstructive surgeons are frequently confronted with
irradiated post-ablative skin and soft tissue defects. Mus-
cle and musculocutaneous flaps have been the traditional
form of reconstruction in these patients, and little is
known about outcomes of split-thickness skin grafts in the
setting of preoperative radiation. In some cases, STSG
must be considered as the reconstructive option in
patients with significant medical comorbidities, recur-
rence in the area of previous flap, or failed flap reconstruc-
tion that is not amenable to microvascular tissue transfer
due to lack of recipient vessels. Historically, reported skin
graft loss rates in preoperatively irradiated wounds varied
from 30% – 100% [1-3].
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Modern practice of reconstructive surgery is changing as
evidenced by the improvement of surgical techniques,
postoperative care, and especially wound care adjuncts.
VAC® therapy may simplify reconstruction and improve
the outcomes of skin grafts in cases of irradiated defects.
The present study was undertaken to evaluate the out-
comes of split-thickness skin grafts (STSGs) following
oncologic resections in patients with musculoskeletal sar-
comas who received preoperative radiation or were
treated with locoregional radiation therapy in the past.
Patients and methods
Retrospective review of the records was conducted to iden-
tify the patients who underwent STSG reconstruction of
irradiated extremity defects in conjunction with Vacuum
Assisted Closure (VAC®) therapy. Between January 1997
and December 2005, records of 19 such patients were
identified and reviewed with permission of our institu-
tional review board. All patients in this group had soft tis-
sue sarcomas (Table 1). Prior to skin grafting, they were
treated with external beam radiation to the tumor bed
with the addition of intraoperative radiation or brachy-
therapy as dictated by treatment protocols.
All patients had a split thickness skin graft placed on an
irradiated recipient bed that otherwise was appropriate for
grafting (exposed muscle, vascularized soft tissue, or gran-
ulation tissue). The decision to reconstruct with a STSG as
opposed to a flap was made by the authors on a case-by-
case basis with consideration of the patient's physiologi-
cal status, oncologic situation, defect characteristics, and
patient's and surgeon's preference. The patients that had
exposed critical structures such as major nerves, blood
vessels, tendons with stripped peritenon, cortical bone,
and avascular joint capsule were not suitable candidates
for grafting, and no such patients were found in the Mayo
Clinic database. Irradiated defects with the exposure of
aforementioned structures were appropriately treated
with flaps.
There were 5 patients with local muscle flaps, which were
unequivocally exposed to a full radiation dose. These
patients were subsequently reconstructed with STSGs. The
patients who had a skin graft applied to an axial pattern
muscle flap, which did not have a full exposure to radia-
tion therapy, were not included in the study. Two patients
who had skin grafts of irradiated recipient beds were
excluded from the study because one had necrosis of the
underlying irradiate muscle flap, and the other had a 40%
of skin graft placed with epidermis facing the recipient
bed (Figure 1). The remaining 17 patients comprised the
study group.
Skin grafting was performed as primary reconstruction at
the time of tumor resection in 8 patients. Five patients had
STSG performed 2 – 8 days following tumor resection as a
delayed-primary reconstruction. During this delay, 3
patients underwent a 6-day course of brachytherapy when
the brachytherapy afterloading catheters were covered
with sterile VAC®dressing (Kinetic Concepts, Inc., San
Antonio, TX). In the remaining 2 patients, the wound was
temporarily covered with VAC® dressing and delayed-pri-
mary skin graft was performed within 2 and 8 days follow-
ing tumor excision when the clear margins of resection
were confirmed with permanent pathology. In these 13
patients who underwent primary or delayed-primary skin
grafting, the time interval from completion of radiation
therapy to skin graft reconstruction varied from 21 to 67
days, average 34 days.
Four patients underwent skin grafting for closure of pre-
operatively radiated complicated wounds. These wounds
were treated with serial débridements and frequent dress-
ing changes, and VAC®  therapy. STSGs were used for
reconstruction when the wound filled with healthy gran-
ulation tissue and was judged amenable to grafting.
All patients underwent reconstruction with 0.012–0.015-
inch split-thickness skin grafts that were applied directly
on the radiated recipient bed. All skin grafts in this series
were meshed 1.5:1 ratio and secured in place with either
staples or chromic suture. Xeroform gauze® (Tyco Health-
care Group, Mansfield, MA) or Furacin®(Shire US, Inc.
Newport, KY) ointment on N-Terface® Interpositional Sur-
face Material (Winfield Laboratories, Inc. Richardson, TX)
were placed directly onto the skin graft prior to the VAC®
dressing application. Inpatient VAC® therapy at 75 mm Hg
in continuous mode was instituted to secure the split-
thickness skin graft in place until postoperative day 5.
Table 1: Histologic characteristics and distribution of primary 
tumors
Histology
Malignant fibrous histiocytoma 6
Fibrosarcoma 3
Liposarcoma 3
Angiosarcoma 1
Leiomyosarcoma 1
Synovial 1
Chondrosarcoma soft tissues 1
Fibromyxosarcoma 1
Tumor location
Thigh 8
Lower leg 6
Upper arm 2
Forearm 1
Total patients 17World Journal of Surgical Oncology 2007, 5:138 http://www.wjso.com/content/5/1/138
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During this time, the patients with lower extremity
wounds were kept on bed rest. On the fifth postoperative
day, the VAC® dressing was taken down. Following dis-
charge, the patients performed Xeroform gauze® dressing
changes once or twice a day for 4 – 6 weeks. All patients
had the wounds re-examined postoperatively as a part of
their oncologic follow up. Skin graft take was judged by
gross inspection, and this information was extracted from
the medical records. The end point of the study was com-
plete healing of the wound with stable skin coverage.
Results
Patients and oncologic treatments
Skin grafts were performed on 17 patients (9 men and 8
women, age 42 to 82, mean 65). The sizes of skin grafts
varied from 23 cm2  to 240 cm2, mean 118 cm2. All
patients had histologically confirmed high-grade (grade 3
or 4) soft tissue sarcomas (Table 1). Two patients had dia-
betes mellitus, one was a smoker, and none were on ster-
oids. The usual radiation dose was from 50 to 62 Gy with
the exception of one patient with a recurrent tumor who
received a total of 100-Gy to his recipient bed prior to skin
graft reconstruction. On average, the patients received a
cumulative dose of 59.3 Gy, ranging from 50 Gy 100 Gy.
Reconstructive settings
Thirteen patients underwent skin grafting under sterile
conditions in the setting of either immediate (primary) or
delayed-primary reconstruction. In 4 patients, skin grafts
were performed for tertiary intention closure of compli-
cated wounds following surgical site infection and break-
down of primary closure (3 patients) and flap necrosis (1
patient). Thirteen patients had a STSG placed directly on
a defect, and 4 patients had it applied to irradiated local
muscles flaps (tibialis anterior – 2 and rectus femoris – 2).
Graft healing
Twelve skin grafts (71%) had greater than 95% graft take
and healed completely by primary intention; 3 patients
(18%) lost between 6% and 20% of the graft surface; and
Forty percent graft surface failure of the irradiated defect due to upside down application of the skin graft Figure 1
Forty percent graft surface failure of the irradiated defect due to upside down application of the skin graft. Notice prominence 
of granulation tissue in the irradiated wound in the area of failed skin graft in response to 4 days of VAC therapy (A). Interval 
healing progress after 7 weeks of local wound care (B).World Journal of Surgical Oncology 2007, 5:138 http://www.wjso.com/content/5/1/138
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2 patients lost their entire graft. Three patients healed by
secondary intention: 2 patients with 10% and 20% skin
graft loss healed with dressing changes only and 1 patient
with complete graft loss healed with wound VAC® therapy.
Overall, 15 of 17 patients (88%) healed without further
operative intervention, and only 2 patients required reop-
eration for tertiary intention closure of the defect. One
patient with 10% graft loss with exposed tendons of the
forearm required a free hemi-latissimus dorsi muscle flap,
and the other patient with complete graft loss was sal-
vaged with medial gastrocnemius muscle flaps (Table 2).
VAC therapy and grafting results
VAC® dressing was utilized in all patients to secure the
STSG during the early postoperative period. Additionally,
VAC® therapy was used for temporary sterile closure of
open wounds (5 patients) that allowed delivering brachy-
therapy (3 patients) and obtaining permanent margins (2
patients) without committing to definitive reconstruc-
tion. Four patients with complicated irradiated wounds (3
wound infections and 1 flap loss) were managed with
serial débridements to achieve control of the wound.
Until granulation tissue build up was attained, these
wounds were treated with VAC® therapy for 16 to 88 days,
average 48 days. All 4 patients were skin grafted and suc-
cessfully healed. Time intervals between skin grafting and
completion of preoperative external beam radiation in
these patients were 61, 93,123, and 584 days; they had
had open wounds for 51, 46, 82, and 16 days, respec-
tively.
One patient deserves a special mention. This patient was
originally treated with 45 Gy external beam radiation for
primary synovial sarcoma of the lower leg, and the tumor
was excised and closed primarily. The patient developed a
local recurrence 2 years later and underwent wide-local
excision with 35 Gy brachytherapy over the open wound.
The defect was reconstructed with a STSG that initially
healed, but was lost after receiving a 20-Gy course of addi-
tional postoperative external beam radiation therapy to
the operated site. At that point, the wound was managed
with VAC® therapy for 16 days until it filled with granula-
tion tissue and then was successfully skin grafted after a
cumulative radiation dose of 100 Gy.
Discussion
Split-thickness skin grafts can be used in conjunction with
VAC® therapy for reconstruction of irradiated defects with
acceptable results following preoperative radiation ther-
apy of soft tissue sarcomas or remote exposure to radia-
tion.
DNA damage is a hallmark of radiation injury to the cell
that occurs during radiation therapy. This renders certain
susceptible cells, particularly rapidly dividing tumor cells,
reproductively incompetent and leads to cell program cell
death, apoptosis. While many cells die, those which sur-
vive and continue to function have considerably impaired
functions and proliferative capacity. This results in com-
promised wound healing, susceptibility to infections, and
marked increase of postoperative wound morbidity [4-6].
These changes however occur in phases. Acute irradiation
of the tissues over a short time leads to the initial increase
in vascularity that peaks in the second week and then
gradually decreases during 4th through 6th weeks as the
wound passes the period of subacute inflammation. After
the 8th  week, vascular density in irradiated wounds
becomes lower than it is in controls [7]. These microcircu-
latory changes are similar to those following radiation
therapy and are related to endarteritis obliterans, fibrosis,
disseminated thrombosis of the small vessels and chronic
ischemia of the tissues [5,8]. Reconstruction is best carried
out at the same time or within 4 – 6 weeks of resection,
before chronic fibrous reaction sets in [8,9].
Surgery in an irradiated field requires sound clinical judg-
ment. Every plastic surgery technique has been applied to
reconstruction of radiated wounds, but there is no simple
algorithm in deciding an optimal reconstructive strategy.
Although analysis of anatomic characteristics of the defect
is guided by general reconstructive principles, the deci-
sions should be made with considerations of extent of
radiation damage to the tissues, plans for adjuvant treat-
ments and postoperative surveillance, and functional
demands of the patient [2]. Operability and wound heal-
ing of an oncologic patient may be affected by malnutri-
tion, anemia, immunosuppression, blood transfusions,
chemotherapy, and often age-related medical conditions
[10]. Surgical procedures in an irradiated field emphasize
Table 2: Outcomes of split-thickness skin grafts with VAC utilization in 19 consecutive patients with irradiated extremity wounds
Healing of grafted wound (intention)
Graft take (%) Graft (n) Primary Secondary Tertiary (salvage procedures)
95–100 12 (70.6%) 12 - -
80–94 3 (17.6%) - 2 1* (free flap)
0% 2(11.7) - 1** 1 (Gastroc flap)
* Exposed tendons
**VAC therapy onlyWorld Journal of Surgical Oncology 2007, 5:138 http://www.wjso.com/content/5/1/138
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sterility to prevent bacterial contamination since these
wounds are prone to infection. Meticulous operative tech-
nique calls for atraumatic tissue handling, tension-free
closure, and obliteration of all dead spaces [6]. Wide, his-
tologically-controlled, negative margins must be assured
and, if local control of the tumor is in question, the tumor
bed should be readily accessible to surveillance.
Pedicled or free muscular and musculocutaneous flaps
allow bringing well-vascularized distant tissue from out-
side the radiation field that is resilient to both postopera-
tive external beam radiation therapy and brachytherapy.
They have an established track record in post-radiation
reconstruction because they provide stable coverage,
enhance wound healing, and decrease risk of wound
breakdowns and infections [3,11]. Microvascular tissue
transfer allows the greatest versatility in reconstruction of
three-dimensional irradiated defects especially in the
head and neck region. They can be safely anastomosed
with irradiated vessels of the recipient site [12,13]. Distant
non-irradiated pedicle flaps are a great asset, but within
the radiated field they can be treacherous, and their use in
chest wall reconstruction resulted in 32% wound compli-
cation rate and 14% total flap loss [14]. One of five irradi-
ated local muscle flaps was lost in the present study,
leading to the complete failure of the skin graft and an
amputation of the extremity.
Split-thickness skin grafting is simple to perform and has
a low morbidity. If final margins are found positive,
prompt re-excision can be performed without the need of
excision of the flap along with all the tissue planes of dis-
section and surgical drain tracks that were intraoperatively
seeded with tumor. It facilitates oncologic surveillance of
the tumors with a high rate of local recurrence, such as
many soft tissue sarcomas. Concerns have been voiced
regarding the use of STSGs in the setting of preoperative
and postoperative radiation therapy, and this issue
remains controversial. Animal data suggested that STSGs
were vulnerable to adjuvant radiation and tolerated doses
within only 25 Gy limit [15]. On the other hand, 90% of
patients retained stability of their wound coverage with
STSG following adjuvant radiation (59 ± 0.9 Gy) in the
study from Memorial Sloan-Kettering Cancer Center [16].
There is no agreement about the use of STSGs for recon-
struction of irradiated wounds. High failure rates without
clear correlation with the radiation doses were historically
reported in the literature [1-3] and no clear data on skin
graft outcomes in irradiated wounds have been published
to date. Because skin graft take is largely dependent on
inosculation and neovascularization, failure of the STSG
in an irradiated field was ascribed to vascular phenomena
[9,17]. Changes in the vascular bed and fibrosis associated
with the ensuing chronic phase of radiation insult nega-
tively influence the result of reconstructive operations.
While in mild-to-moderate radiation impairment of the
tissues, skin grafting could be considered [6], the success
of skin grafts in an irradiated field is unpredictable.
Rudolph reported 100% skin graft loss requiring reopera-
tion regardless whether or not irradiated wounds were
excised [3].
Laboratory and clinical studies have shown that the VAC®
therapy increases wound blood flow, granulation tissue
formation, and decreases accumulation of fluid and bac-
teria [18]. Recently, conformational changes in the
cytoskeleton of the cells in response to application of
micromechanical forces, i.e. stretch of the wound surface
by the irregularity of the VAC sponge, was postulated to be
an important factor in VAC-augmented wound healing
[19]. Similar mechanism of stretch-induced cell prolifera-
tion is thought to be the driving force in tissue expansion
[20,18,21] and distraction osteogenesis [22,23]. Initially
applied for treatment of the chronic wounds, it was found
to be useful in the management of acute wounds as well.
VAC® therapy has been shown to hasten wound closure
and the formation of granulation tissue in a variety of set-
tings [24-26].
VAC® dressings are successfully used for securing skin
grafts [24,25,27], especially in wounds with exudative,
irregular, or mobile recipient beds and in difficult ana-
tomic locations [25,28-30]. The manufacturer guidelines
recommend continuous mode negative pressure of 75
mm Hg to 125 mm Hg [31]. We traditionally used 75 mm
Hg for skin graft application although 125 mmHg nega-
tive pressure has also been used by other authors
[25,27,32,33]. The VAC® stabilizes the skin graft and con-
forms well to the shape of recipient bed, removes fluid,
decreases bacterial counts, and provides a secured dress-
ing [27]. Improved graft survival and reduced need for
repeat skin grafting were noted in one retrospective study
[32].
The function of the VAC® technique in irradiated wounds
is largely unknown and clinical experience is very limited
[34]. In the present study, VAC® technique was used in the
vast majority of patients in four types of settings: coverage
of afterloading catheters during brachytherapy, optimiza-
tion of the wound prior to grafting, securing the split-
thickness skin graft, and secondary closure of skin graft
losses.
Immediate flap reconstruction has been traditionally
advocated for coverage of afterloading brachytherapy
catheters [35,36]. Utilization of the VAC® in lieu of imme-
diate flap reconstruction in sarcoma patients requiring
brachytherapy provided rapid and simple temporary cov-
erage with good stability of the catheters. It allows sparingWorld Journal of Surgical Oncology 2007, 5:138 http://www.wjso.com/content/5/1/138
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the flap form radiation insult and performing an elective
delayed reconstruction after completion of brachytherapy
[30]. Patients who underwent flap reconstructions were
not included in this series. However, further study is indi-
cated concerning the effects of temporary VAC® coverage
on brachytherapy effectiveness. Theoretically, the
increased blood flow and oxygenation may minimize
postoperative tissue ischemia and improve effectiveness
of brachytherapy.
VAC® therapy was also used for preoperative optimization
of irradiated wounds to allow skin grafting of a viable,
granulating bed as well as secondary closure of the skin
graft breakdowns. Radiation primarily impairs small ves-
sels, decreases their size and density [17], which causes
local hypoxemia, decreased bacterial clearance, and
impaired regeneration, but the VAC® counteracts all these
effects. It quadruples local blood flow, promotes delivery
of oxygen and nutrients, decreases bacterial counts,
increases size and density of capillaries, and promotes the
growth of granulation tissue [18,24,37,38]. Successful
skin graft take was achieved in one patient who received a
cumulative local dose of 100 Gy as a result of VAC® utili-
zation for optimization of the wound and graft applica-
tion.
The present study retrospectively analyzed a group of
extremity sarcoma patients who received compatible
doses of preoperative radiation and had a close follow up.
These data give insight into the clinical behavior of STSGs
following standard doses of preoperative radiation ther-
apy commonly used in soft tissue sarcoma treatment.
Despite small breakdowns of the skin grafts that eventu-
ally healed and are common in non-irradiated grafts, only
2 patients (11.7%) had complete graft loss. Eighty-eight
percent of patients in this study eventually healed without
requiring further operative procedures. The data demon-
strate that the reconstruction of the suitable irradiated soft
tissue wounds with STSG in conjunction with VAC® ther-
apy may be considered as an acceptable reconstructive
approach in the setting of questionable margins, high risk
of recurrence, and poor physiological condition of the
patient.
Conclusion
Split-thickness skin grafting provides a simple one-stage
reconstructive option for skin and soft tissue defects, but
its use in the irradiated wound is controversial. In the
present study of skin-grafting of post-ablative defects in
the preoperatively radiated soft tissue sarcoma patients,
we found that with meticulous surgical technique and uti-
lization of VAC® therapy complete or partial skin graft take
and complete healing of the wound without reoperation
was achieved in 88% of cases. Complete (>95%) skin graft
take was observed in 71% of cases, partial (80%–94%)
take in 18%, and complete loss of the graft in 12%. Only
12% of skin-grafted wounds required closure with an
additional operation. Split-thickness skin graft reconstruc-
tion of irradiated skin defects can be performed following
preoperative radiation therapy of soft tissue sarcoma
patients in conjunction with VAC® therapy with accepta-
ble skin graft take rate and minimal morbidity to the
patients.
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